These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 22469324

  • 1. Varenicline.
    Kassem MG, Al Hossaini AM.
    Profiles Drug Subst Excip Relat Methodol; 2012; 37():389-411. PubMed ID: 22469324
    [No Abstract] [Full Text] [Related]

  • 2. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.
    Coe JW, Brooks PR, Vetelino MG, Wirtz MC, Arnold EP, Huang J, Sands SB, Davis TI, Lebel LA, Fox CB, Shrikhande A, Heym JH, Schaeffer E, Rollema H, Lu Y, Mansbach RS, Chambers LK, Rovetti CC, Schulz DW, Tingley FD, O'Neill BT.
    J Med Chem; 2005 May 19; 48(10):3474-7. PubMed ID: 15887955
    [Abstract] [Full Text] [Related]

  • 3. Molecule of the Month. Varenicline tartrate.
    Drug News Perspect; 2006 Apr 19; 19(3):162. PubMed ID: 16804568
    [No Abstract] [Full Text] [Related]

  • 4. Practical implementation of varenicline as an aid to smoking cessation in clinical practice.
    Tonstad S.
    Pneumologia; 2009 Apr 19; 58(3):167-74. PubMed ID: 19817313
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Smoking cessation: an overview of treatment options with a focus on varenicline.
    Stack NM.
    Pharmacotherapy; 2007 Nov 19; 27(11):1550-7. PubMed ID: 17963463
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Quitting smoking without a psychotic break: the potential link between nicotinic acetylcholine receptor partial agonists and neuropsychiatric adverse events.
    O'Malley P.
    Clin Nurse Spec; 2009 Nov 19; 23(1):13-5. PubMed ID: 19098509
    [No Abstract] [Full Text] [Related]

  • 13. Varenicline reduced smoking behaviour in a mentally ill person.
    Ochoa EL.
    J Psychopharmacol; 2009 May 19; 23(3):340-1. PubMed ID: 18562426
    [No Abstract] [Full Text] [Related]

  • 14. Utilization management for smoking cessation pharmacotherapy: varenicline rejected claims analysis.
    Zeng F, Chen CI, Mastey V, Zou KH, Harnett J, Patel BV.
    Am J Manag Care; 2010 Sep 19; 16(9):667-74. PubMed ID: 20873954
    [Abstract] [Full Text] [Related]

  • 15. A case of late-life onset mania during Varenicline assisted smoking cessation.
    Francois D, Odom A, Kotbi N.
    Int J Geriatr Psychiatry; 2011 Jun 19; 26(6):658-9. PubMed ID: 21480382
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of varenicline for smoking cessation.
    Hays JT, Ebbert JO, Sood A.
    Am J Med; 2008 Apr 19; 121(4 Suppl 1):S32-42. PubMed ID: 18342165
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [New drugs; varenicline].
    van Bronswijk H, Dubois EA, Zitman FG, Cohen AF.
    Ned Tijdschr Geneeskd; 2007 Nov 10; 151(45):2503-4. PubMed ID: 18062594
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.